MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE >  Moneycontrol >  Markets > Announcements >  Pharmaceuticals > Announcement - Dr Reddys Labs
Dr Reddys Labs
BSE: 500124NSE: DRREDDYISIN: INE089A01023

25th-Jan-2013 11:50Source: BSE

Dr Reddys Labs - Dr. Reddy's announces the Launch of Desloratadine ODT (Orally Disintegrating Tablets)

Dr Reddys Laboratories has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex Reditabs in the US markets on January 24, 2013.

More Announcements on:

20th-May-2013 16:43Source: BSE

Dr Reddys Labs - Fixes Book Closure for Dividend & AGM

16th-May-2013 16:00Source: NSE

Dr. Reddy's Laboratories Limited

15th-May-2013 20:55Source: NSE

Dr. Reddy's Laboratories Limited

15th-May-2013 18:02Source: BSE

Dr Reddys Labs - Grant of Stock Options

14th-May-2013 15:02Source: NSE

Dr. Reddy's Laboratories Limited

14th-May-2013 14:11Source: BSE

Dr Reddys Labs - Board recommends Final Dividend

13th-May-2013 15:14Source: BSE

Dr Reddys Labs - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

9th-Apr-2013 20:52Source: NSE

Dr. Reddy's Laboratories Limited

8th-Apr-2013 19:51Source: BSE

Dr Reddys Labs - FY 13 results on May 14, 2013

4th-Apr-2013 12:17Source: BSE

Dr Reddys Labs - Dr. Reddy's Announces the Launch of Zoledronic Acid Injection

1 2 3 4 5 Next >>
Add to Watchist
close[x]
Have you invested in these stocks? You can track them better in your Portfolio
Edit Watchlist
JSW Steel Q4 net dips 24% as shortages of iron ore forced it to operate below capacity. Does the mining sector in India require a boost?
Yes
No

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window